It has been over 50 years since humankind first went to space and stepped on the moon, and space remains a perilous frontier for both people and companies. While scientists and science fiction enthusiasts expected space to be the largest industry of the 21st century, space companies have instead languished in relative obscurity. For a
In an era when data reigns supreme, few sectors shine as brightly as that of machine learning. Leading machine learning stocks are carving out a notable niche for tech-savvy investors. These aren’t merely fleeting trends or temporary boosts. The high-potential stocks we’re about to discuss represent the nexus of innovation and opportunity. While “must-buy machine
In hindsight, Meta Platforms (NASDAQ:META) stock was clearly a “can’t miss” contrarian opportunity late last year, when the tech giant traded for as little as $88.09 per share. Since then, META stock has rallied by around 246%, thanks to favorable company-related and sector-related developments. However, while it may be a longtime before the Facebook and
Following what billionaires and investing gurus are doing isn’t a bad strategy. Looking at their top stocks to buy is at least a good first step for beginning your investment journey. But if always blindly buying what they bought was a successful strategy, we’d all be millionaires. Quite often, the smartest guys in the room are
As much as I love good dividend stocks, I have very little patience for F-rated dividend stocks that do nothing but drag your portfolio down. As an investor, you deserve better! A great dividend stock can make all the difference in your portfolio. By reinvesting dividends, growth investors can increase their positions and investing power
The U.S. equity valuations continue their remarkable trend upward, well beyond anyone’s expectations in 2023. The major indices appreciated amid expectations of a soft landing for the economy as the Federal Reserve battles inflation. While inflation still sits above the Federal Reserve’s target, it is well below where it was 12 months ago. However, despite
With the world going green, some of the most explosive opportunities can be found in hydrogen stocks. Analysts at Markets and Markets say the market could be worth $410.6. billion by 2030. Goldman Sachs (NYSE:GS) says we could be looking at a $1 trillion opportunity by 2050. Meanwhile, the U.S. Department of Energy just said
Chimerix (NASDAQ:CMRX), like most clinical-stage biotech stocks, is without question a high-risk play. Yet in contrast to other biotechs, where high potential rewards can outweigh this high risk, that is not necessarily the case here with CMRX stock. Sure, on paper, Chimerix’s future prospects appear very promising. Last year, the company sold a treatment that